Researchers uncover potentially promising therapeutic combination for renal cell carcinoma
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new
Read more
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new
Read moreThe mental symptoms of premenstrual dysphoric disorder improve following treatment with a progesterone receptor modulator, as demonstrated by SciLifeLab researcher
Read moreToday, OncoTartis, Inc. and Children’s Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal
Read moreIn a new Yale-led study, investigators have revealed previously unknown factors that contribute to the hardening of arteries and plaque
Read moreNoonan Syndrome (NS) is a rare genetic syndrome typically evident at birth and often linked to early-onset severe heart disease.
Read moreResearch into a new breakthrough therapy in the fight against sepsis has shown that the drug has potential to stop
Read moreA team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD),
Read moreTherapy assisted by a dog could be more effective than standard speech and language therapy for children with communication impairments,
Read moreTHURSDAY, Sept. 13, 2018 — A score based on the results of three laboratory tests has higher sensitivity and specificity
Read moreA group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the virus
Read more